HRI clinicians in world first: Translational Research Group

Research Updates

Coronary artery disease, where plaque or fat builds up on the inner walls of the arteries to the heart, reducing blood flow, is the most common cause of death worldwide.

Angioplasty, the procedure used to treat coronary artery disease, is performed on more than four million people worldwide each year.

However up to 30 per cent suffer a degree of heart damage following the procedure because the balloons or stents, used to open narrowed arteries, can dislodge plaque, pushing it downstream towards the capillaries, or microcirculation, and causing blockages.

Until now there has been no way of predicting which patients were at risk.

In breakthrough research published August 1st 2012 in the peer-reviewed journal Circulation: Cardiovascular Interventions, Clinicians from The Heart Research Institute,  Stanford University in California and Sydney Local Health District have shown for the first time that the health of those capillaries strikingly predicts a patient’s risk of heart damage at the time of angioplasty.

By measuring the health of the heart capillaries of patients before they undergo angioplasty, they were able to predict those who were at risk of heart damage from angioplasty. Patients with impaired heart capillaries were found to have a 60 percent risk of heart damage after angioplasty.

“We were stunned by the findings of this study,” co-lead researcher and Translational Group Leader, Dr Martin Ng, said.

“Angioplasty is one of the most common cardiac procedures in the world, yet the causes of heart damage from angioplasty are not fully understood and there are no easy means of identifying patients at risk.” Dr Ng said. “We demonstrate for the first time that the health of your heart capillaries is a key determinant of your risk of heart damage from angioplasty and demonstrate a method to identify patients who are at risk”.

Patients shown to be at risk could be given preventative treatment.

Those identified can be given strong intravenous blood thinners before the angioplasty goes ahead, or we can use small filters to capture the plaque, preventing it from lodging in smaller vessels.

Previous

Related news

Glowing Stem Cells Mend Broken Hearts

HRI researcher is heralding hope for broken hearts with a cutting-edge tool that helps scientists fast-track exciting new therapies to mend damaged organs.

Richard Tan from the Heart Research Institute in Sydney has developed a glowing stem cell tracker model that could change the way the science community develops life-saving tissue therapies.

Read more

World Health Day 2016: Beat diabetes

Today is World Health Day, a global health awareness day held annually on April 7.

Each year attention is drawn to a different global health issue with this year being diabetes.

Read more

Unravelling the link between diabetes and heart disease

Researchers at The Heart Research Institute are the first in the world to uncover a link between diabetes and cardiovascular disease, a discovery that has the potential to save millions of lives.
Read more